Active Ingredient History

NOW
  • Now
Telcagepant (INN) is a calcitonin gene-related peptide receptor antagonist which was an investigational drug for the acute treatment and prevention of migraine, developed by Merck & Co..   Wikipedia

  • SMILES: Oc1nc2ncccc2n1C3CCN(CC3)C(=O)N[C@@H]4CC[C@H](CN(CC(F)(F)F)C4=O)c5cccc(F)c5F
  • InChIKey: CGDZXLJGHVKVIE-DNVCBOLYSA-N
  • Mol. Mass: 566.53
  • ALogP: 4.1
  • ChEMBL Molecule:
More Chemistry
mk0974 | mk 0974 | mk-0974 | n-((3r,6s)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)hexahydro-1h-azepin-3- yl)-4-(2-oxo-2,3-dihydro-1h-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxamide | n-(6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl)-4-(2-oxo-2,3-dihydro-1h-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxamide | talcagepant | tecagepant | telcagepant

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue